Đang chuẩn bị liên kết để tải về tài liệu:
Isolated adrenocorticotropic hormone deficiency and sialadenitis associated with nivolumab: A case report

Không đóng trình duyệt đến khi xuất hiện nút TẢI XUỐNG Tải xuống

Immune checkpoint inhibition with anti-PD(L)1 and anti-CTLA4 antibodies has significantly changed cancer treatment during the last 10 years. Nevertheless, boosting the immune system with immune checkpoint inhibition can result in immune-related adverse events, affecting different organ systems, among which the endocrine system is the most affected. |